Erin Doherty

3.2k total citations
26 papers, 498 citations indexed

About

Erin Doherty is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Erin Doherty has authored 26 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Erin Doherty's work include RNA and protein synthesis mechanisms (7 papers), RNA regulation and disease (6 papers) and CRISPR and Genetic Engineering (6 papers). Erin Doherty is often cited by papers focused on RNA and protein synthesis mechanisms (7 papers), RNA regulation and disease (6 papers) and CRISPR and Genetic Engineering (6 papers). Erin Doherty collaborates with scholars based in United States, United Kingdom and China. Erin Doherty's co-authors include Peter E. Zage, Sibo Zhao, Valeria Smith, Sarah Burkhead Whittle, Peter A. Beal, Jennifer A. Doudna, Nathan Price, Jason Nomburg, Daniel Bellieny‐Rabelo and Andrew J. Fisher and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Erin Doherty

23 papers receiving 489 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Erin Doherty	277	233	94	76	46	26	498
Vito Alessandro Lasorsa	286 1.0×	237 1.0×	230 2.4×	113 1.5×	38 0.8×	36	546
Zi‐Xuan Wang	139 0.5×	178 0.8×	58 0.6×	80 1.1×	45 1.0×	13	500
Chase J. Taylor	317 1.1×	43 0.2×	104 1.1×	66 0.9×	44 1.0×	17	529
Song Ouyang	158 0.6×	70 0.3×	65 0.7×	51 0.7×	116 2.5×	32	356
Alessandra Cattaneo	150 0.5×	32 0.1×	88 0.9×	47 0.6×	51 1.1×	25	368
Sara E. Vazquez	104 0.4×	136 0.6×	11 0.1×	53 0.7×	140 3.0×	20	389
Ilias Masouris	124 0.4×	25 0.1×	40 0.4×	122 1.6×	131 2.8×	23	354
Lielian Zuo	404 1.5×	26 0.1×	241 2.6×	199 2.6×	72 1.6×	17	618
Charlotte Jubert	103 0.4×	31 0.1×	23 0.2×	52 0.7×	33 0.7×	32	347
Maria Cannone	60 0.2×	80 0.3×	18 0.2×	66 0.9×	26 0.6×	24	319

Countries citing papers authored by Erin Doherty

Since Specialization

Citations

This map shows the geographic impact of Erin Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Doherty more than expected).

Fields of papers citing papers by Erin Doherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Doherty. The network helps show where Erin Doherty may publish in the future.

Co-authorship network of co-authors of Erin Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Doherty. A scholar is included among the top collaborators of Erin Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Doherty. Erin Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Honglue, Kevin Wasko, Marena Trinidad, et al.. (2025). Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing. Molecular Cell. 85(9). 1730–1742.e9. 3 indexed citations

Doherty, Erin, Benjamin A. Adler, Peter H. Yoon, et al.. (2025). A miniature CRISPR–Cas10 enzyme confers immunity by inhibitory signalling. Nature. 647(8091). 997–1004. 3 indexed citations

Doherty, Erin, Jason Nomburg, Benjamin A. Adler, et al.. (2025). Divergent viral phosphodiesterases for immune signaling evasion. Cell Host & Microbe. 33(12). 2043–2051.e6.

Shi, Honglue, Kevin Wasko, Marena Trinidad, et al.. (2025). BPS2025 - Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing. Biophysical Journal. 124(3). 90a–90a. 1 indexed citations

Chen, Kai, Katarzyna M. Soczek, Erin Doherty, et al.. (2024). Rapid DNA unwinding accelerates genome editing by engineered CRISPR-Cas9. Cell. 187(13). 3249–3261.e14. 29 indexed citations

Nomburg, Jason, et al.. (2024). Birth of protein folds and functions in the virome. Nature. 633(8030). 710–717. 38 indexed citations

Trinidad, Marena, Hunter Nisonoff, Seyone Chithrananda, et al.. (2024). RNA language models predict mutations that improve RNA function. Nature Communications. 15(1). 10627–10627. 8 indexed citations

Doherty, Erin, et al.. (2024). Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5′-GA Sites. Biomolecules. 14(10). 1229–1229. 3 indexed citations

Wu, Meng-Fen, Tao Wang, Erin Doherty, et al.. (2023). Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 30(2). 217–227. 4 indexed citations

10.

Doherty, Erin & Robert A. Krance. (2023). Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?. Hematology. 2023(1). 171–174.

11.

Friend, Brian D., Ibrahim N. Muhsen, Shreeya Patel, et al.. (2022). Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplantation. 57(4). 579–585. 1 indexed citations

12.

Doherty, Erin, et al.. (2022). ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site. Nucleic Acids Research. 50(19). 10857–10868. 21 indexed citations

13.

Friend, Brian D., Ghadir Sasa, Bilal Omer, et al.. (2021). Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children’s Hospital experience. Bone Marrow Transplantation. 56(11). 2797–2803. 4 indexed citations

14.

Doherty, Erin, et al.. (2021). Regulation of RNA editing by intracellular acidification. Nucleic Acids Research. 49(7). 4020–4036. 19 indexed citations

15.

Doherty, Erin, et al.. (2021). Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position. Journal of the American Chemical Society. 143(18). 6865–6876. 19 indexed citations

16.

Doherty, Erin, Yixuan Xie, Anil K. Padyana, et al.. (2020). High-throughput mutagenesis reveals unique structural features of human ADAR1. Nature Communications. 11(1). 5130–5130. 14 indexed citations

17.

Doherty, Erin, Michele S. Redell, Ghadir Sasa, et al.. (2019). Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era. Blood. 134(Supplement_1). 2056–2056. 3 indexed citations

18.

Doherty, Erin, Abishek Vaidya, Challice L. Bonifant, et al.. (2018). Improving CD123-Targeted T-Cell Therapy for Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 24(3). S232–S232. 1 indexed citations

19.

Whittle, Sarah Burkhead, et al.. (2017). Overview and recent advances in the treatment of neuroblastoma. Expert Review of Anticancer Therapy. 17(4). 369–386. 276 indexed citations

20.

Walker‐Bone, Karen, et al.. (2016). Assessment and management of musculoskeletal disorders among patients living with HIV. Lara D. Veeken. 56(10). kew418–kew418. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact